National Patient Safety Alert: Shortage of Antimicrobial Agents Used in Tuberculosis (TB) Treatment
National Patient Safety Alert: Shortage of Antimicrobial Agents Used in Tuberculosis (TB) Treatment National Patient Safety Alert Reference Number: NatPSA/2025/004/MVA Date issued: 29 July 2025 Explanation of identified issue: The following antimicrobial medicines used to treat tuberculosis (TB) will be intermittently available until at least the end of 2025: Rifampicin 150mg and 300mg capsules Rifampicin [...]
The post National Patient Safety Alert: Shortage of Antimicrobial Agents Used in Tuberculosis (TB) Treatment appeared first on Community Pharmacy England.
Recent Comments